The 12 Labs Every Adult 45+ Should Run — and the Optimal Ranges Most Doctors Won't Tell You
The standard physical orders a sliver of what your insurance will pay for. This dossier covers the twelve markers we'd actually want, what they mean past 45, and the ranges that the longevity literature uses — not the ones printed on the lab slip.
Most "your bloodwork is normal" conversations end too soon. "Normal" on a lab report is a population reference range — the middle 95% of who showed up at that lab. It is not an optimal range, and it is rarely tuned for an adult past 45. What follows is the list we'd hand a friend.
For each marker: why it matters, what your lab will print as "normal," the tighter optimal target the longevity literature uses, the level at which we'd act, and the one question to bring to the consult. None of this replaces a clinician — it makes the conversation sharper.
HbA1c
A three-month average of your blood sugar — the single best early-warning marker for the slow drift into insulin resistance.
ApoB (apolipoprotein B)
Counts the actual number of atherogenic particles in your blood — a far better cardiovascular risk marker than LDL-C alone (Sniderman 2019).
Fasting Insulin
Rises years before glucose does. Insulin resistance is the engine behind the cortisol-belly, the 3 p.m. crash, and most "I'm not eating that much" weight stories at 50.
Free + Total Testosterone (men) / FSH + Estradiol (women)
The single most under-ordered set of labs in midlife. The complaints we hear — flat mood, fog, soft middle, dead libido — often map onto sex-hormone shifts well before a clinician thinks to test for them.
Full Thyroid Panel (TSH, Free T3, Free T4)
TSH alone misses subclinical hypothyroidism. Free T3 is the active hormone — and it's the one nobody orders.
Vitamin D (25-OH)
Underrated for bone, mood, immune, and — in women — the perimenopause transition. The lab cutoff is set so low that most adults clear it on paper while running suboptimal.
Ferritin
Iron stores. Women lose ferritin every month until they don't; once they don't, it climbs. Both ends matter past 45.
hs-CRP
High-sensitivity C-reactive protein. The cheapest, fastest read on chronic low-grade inflammation — the engine behind a lot of midlife disease.
Lipid Panel with Particle Size (NMR or ion-mobility)
The standard panel is a 1980s tool. NMR particle profiles — LDL-P, small dense LDL, Lp(a) — tell you whether the cholesterol number on the slip actually carries risk.
DHEA-S
An adrenal hormone that quietly underwrites energy, libido, mood, and bone. Declines about 2% per year after 30 — faster under chronic stress.
RDW (red cell distribution width)
The most underused marker on your CBC. A rising RDW — even within "normal" — is one of the strongest all-cause mortality signals in the literature.
Homocysteine
Methylation marker tied to cardiovascular and cognitive risk. Cheap to lower with B-vitamins if it's high. Almost never ordered.
Want the deeper Decoder?
The $19 Bloodwork Decoder walks through 8 follow-up scenarios when these come back yellow — the "your number is fine, but…" conversations. What the next test should be, what to actually change, and which letter to read next.
Sources & Further Reading
- Sniderman AD, et al. "Apolipoprotein B Particles and Cardiovascular Disease." JAMA Cardiology, 2019.
- Endocrine Society. "Testosterone Therapy in Men With Hypogonadism: Clinical Practice Guideline." 2018.
- AACE / ACE. "Clinical Practice Guidelines for the Diagnosis and Management of Dyslipidemia and Prevention of Cardiovascular Disease." 2017, updated 2022.
- Berkeley HeartLab NMR Lipoprotein Reference Ranges, technical documentation.
- UCLA Center for Human Nutrition — reference ranges for fasting insulin and HOMA-IR.
- Endocrine Society. "Evaluation, Treatment, and Prevention of Vitamin D Deficiency." Clinical Practice Guideline, 2011 (reaffirmed).
- Ridker PM, et al. JUPITER trial. N Engl J Med, 2008.
- Patel KV, et al. "Red Cell Distribution Width and Mortality." Arch Intern Med, 2010.
- de Jager J, et al. VITACOG trial (homocysteine, B-vitamins, cognitive decline). 2010-2014.
- North American Menopause Society (NAMS) 2022 hormone therapy position statement.
Editorial dossier. Educational use only. Not medical advice — bring this to your physician, not in place of them.
FTC/Editorial: After Forty Feel is independent. Some links are affiliate. We earn from qualifying purchases at no extra cost to you. We only link what we would use ourselves. Full standards: here.